Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer.
about
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Phase II trial of paclitaxel-c ...... wn non-small cell lung cancer.
@ast
Phase II trial of paclitaxel-c ...... wn non-small cell lung cancer.
@en
type
label
Phase II trial of paclitaxel-c ...... wn non-small cell lung cancer.
@ast
Phase II trial of paclitaxel-c ...... wn non-small cell lung cancer.
@en
prefLabel
Phase II trial of paclitaxel-c ...... wn non-small cell lung cancer.
@ast
Phase II trial of paclitaxel-c ...... wn non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Phase II trial of paclitaxel-c ...... wn non-small cell lung cancer.
@en
P2093
Jianliang Yang
Jianping Xu
Junling Li
Xiangru Zhang
Xuezhi Hao
Yuankai Shi
P2860
P304
P356
10.1111/1759-7714.12074
P577
2014-03-03T00:00:00Z